Should Hepatitis C Virus Antibody Be Used for Screening Purposes?

Journal Title: Viral Hepatitis Journal - Year 2018, Vol 24, Issue 1

Abstract

Objectives: In this study, hepatitis C virus (HCV) RNA results were retrospectively investigated in patients with reactive HCV antibodies. Materials and Methods: HCV antibody test was performed ELISA method. Enzyme linked fluorescence assay was used as a different method. The quantitative HCV RNA test was carried out by AmpliPrep/COBAS TaqMan HCV test. Results: HCV antibody reactivity was detected in 358 of 28081 samples, 255 samples collected from 358 anti-HCV positive-patients and were tested for HCV RNA were included in the study. The detected HCV RNA positivity rate was 5.8% in patients who had low titer reactive HCV antibody and 76.3% in patients, who had high titer reactive HCV antibody. Nine of 23980 samples, which were screened for preoperative preparation, had reactive HCV RNA. One hundred thirty seven of 4101 samples, which were obtained for diagnostic purposes in the gastroenterology and infectious diseases clinics, were HCV RNA positive. Conclusion: Positive results should be confirmed with HCV RNA testing; if possible, testing for HCV antibodies with other methods, before HCV RNA testing, will decrease the number of tests using molecular methods; and screening for HCV antibodies is not cost-effective especially in populations with a low prevalence of HCV antibody positivity.

Authors and Affiliations

Birol ŞAFAK, Özge TOMBAK, Aynur EREN TOPKAYA

Keywords

Related Articles

Direct-acting Antiviral Therapy for Mixed Genotype Chronic Hepatitis C Infection

Objectives: Literature data concerning the outcomes of direct acting antiviral (DAA) therapy in mixed genotype hepatitis C virus (HCV) infections are very limited, and the incidence of mixed HCV infection in Turkey is un...

Can HBsAg Be Used as a Viral Replication Marker in Chronic Hepatitis B Patients?

Objective: Monitoring hepatitis B virus (HBV) treatment responses and virus replication is performed with molecular tests. However, these tests are either expensive or invasive. A new and more practical marker is needed....

Seven-year Genotype Distribution Among Hepatitis C Patients in a City in the Central Anatolia Region of Turkey

Objectives: Hepatitis C virus (HCV) is an important viral agent of hepatitis, cirrhosis and hepatocellular carcinoma. In our study, we aimed to determine the HCV genotype distribution among patients with HCV who presente...

Evaluation of Hepatitis C Virus Genotype Results in İzmir Atatürk Training and Research Hospital

Objectives: The aim was to support both the clinical treatment and management and also to contribute to the epidemiological understanding of the hepatitis C virüs (HCV) genotype in our region. Materials and Methods: HCV...

Download PDF file
  • EP ID EP364704
  • DOI 10.4274/vhd.0018
  • Views 33
  • Downloads 0

How To Cite

Birol ŞAFAK, Özge TOMBAK, Aynur EREN TOPKAYA (2018). Should Hepatitis C Virus Antibody Be Used for Screening Purposes?. Viral Hepatitis Journal, 24(1), 18-20. https://europub.co.uk/articles/-A-364704